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Abstract
Background: The use of lentiviruses to reprogram human somatic cells into induced pluripotent stem (iPS) cells
could limit their therapeutic usefulness due to the integration of viral DNA sequences into the genome of the
recipient cell. Recent work has demonstrated that human iPS cells can be generated using episomal plasmids,
excisable transposons, adeno or sendai viruses, mRNA, or recombinant proteins. While these approaches offer an
advance, the protocols have some drawbacks. Commonly the procedures require either subcloning to identify
human iPS cells that are free of exogenous DNA, a knowledge of virology and safe handling procedures, or a
detailed understanding of protein biochemistry.
Results: Here we report a simple approach that facilitates the reprogramming of human somatic cells using
standard techniques to transfect expression plasmids that encode OCT4, NANOG, SOX2, and LIN28 without the
need for episomal stability or selection. The resulting human iPS cells are free of DNA integration, express
pluripotent markers, and form teratomas in immunodeficient animals. These iPS cells were also able to undergo
directed differentiation into hepatocyte-like and cardiac myocyte-like cells in culture.
Conclusions: Simple transient transfection of plasmid DNA encoding reprogramming factors is sufficient to
generate human iPS cells from primary fibroblasts that are free of exogenous DNA integrations. This approach is
highly accessible and could expand the use of iPS cells in the study of human disease and development.
Background
Human iPS cells are potentially valuable tools for the
study of human development and disease. If human iPS
cells are generated from specific patients they offer an
opportunity to study the molecular mechanism underly-
ing the pathogenesis [1,2]. Because human iPS cells can
be derived from a patient’s own cells they may ulti-
mately provide the means for effective cell therapy,
avoiding concerns associated with immune rejection.
However, before iPS cell-based therapeutics can be rea-
lized, it is important that a reliable, reproducible, acces-
sible, and safe reprogramming protocol is adopted.
Current human iPS production techniques have sev-
eral limitations that restrict their clinical usefulness. For
example, most reprogramming procedures result in
clones of iPS cells in which the extent of reprogram-
ming can be heterogeneous. The derivation of fully
reprogrammed iPS cells, therefore, requires fastidious
attention to detail with laborious, time-consuming pro-
duction and screening procedures. Recent studies have
suggested that the inclusion of Valproic Acid or Sodium
Butyrate may enhance complete reprogramming [3,4].
In addition to the heterogeneity associated with repro-
gramming, the most commonly used reprogramming
protocols use lentiviruses, which integrate into the host
cell’s genome and are potentially mutagenic. The choice
of using lentiviruses to reprogram is partly historical.
Initial studies showed that the use of lentiviruses to
transduce exogenous factors (OCT4, SOX2, NANOG
and LIN28 or OCT3/4, SOX2, KLF4 and C-MYC) into
genomic DNA was sufficient to reprogram human
somatic cells [5,6]. Since expression of the viral cDNAs
was repressed by methylation this allows transient
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expression of reprogramming factors until endogenous
regulators of pluripotency take over. The transient
expression of reprogramming factors may be important
because even subtle changes in expression of these
genes can induce cell differentiation [7]. Studies using
mouse cells have shown that expression of the exogen-
ous reprogramming factors is required for a minimum
of 12 days to produce iPS cells [8]. Although the need
for extended expression of introduced cDNAs suggested
that the use of non-integrating approaches would be
challenging, Stadtfeld et al. demonstrated that genomic
integration was not essential to successfully reprogram
mouse fibroblasts, by using adenoviruses to supply
cDNAs encoding reprogramming factors [9].
Recently, a number of publications [10,11] have
reported the production of human iPS cells that are free
of transgenic sequences using a variety of strategies
including infection of cells with recombinant adeno-
viruses and sendai viruses. Although the use of these
viruses circumvent genomic integration of DNA, they
require a knowledge of virology to produce high titer
viruses and adherence to increasingly strict biosafety
regulations. Kim et al [12] were able to generate human
iPS cells by directly delivering reprogramming proteins
(OCT4, SOX2, KLF4 and C-MYC). The reprogramming
proteins were fused to a peptide highly enriched in basic
amino acids, which allowed them to cross the cell mem-
brane barrier. The cells were then seeded on mouse fee-
der cells, and human iPS-like colonies were picked 56
days after first exposure to the reprogramming proteins.
This protocol was advantageous as it did not directly
use genetic material to reprogram the somatic cells.
However, one limitation was that a cell extract of stably
transfected HEK-293T cells had to be added once a
week for six weeks.
A number of reports have shown that nucleic acids
that do not integrate into the recipient genome can be
used successfully to make iPS cells. Yu et al [13]
demonstrated that human iPS cells could be generated
from a single nucleofection of three oriP/EBNA1
(Epstein-Barr nuclear antigen-1)-based episomal vectors
coding for seven factors (OCT4, SOX2, NANOG,
LIN28, KLF4, C-MYC, and SV40Tag), after drug selec-
tion and seeding on mouse feeder cells. However,
although the presence of oriP/EBNA1 ensured mainte-
nance of the plasmids even after reprogramming, all
human iPS cells generated by this approach therefore
had to be subcloned to isolate human iPS cell lines void
of vector DNA.
While all of these techniques could be valuable, they
all suffer from a lack of simplicity and in some cases
require substantial knowledge of virology or protein bio-
chemistry. We reasoned that an ideal reprogramming
approach would rely on the use of elementary
procedures that were readily accessible to any lab with
even rudimentary experience in molecular biology. Since
Yu and colleagues [13] had successfully used nucleofec-
tion with episomal vectors, we addressed whether simple
transient transfection of plasmid DNA could generate
human iPS cells. We show that two sequential transfec-
tions of non-episomal plasmids that independently
encode four reprogramming factors (OCT4, NANOG,
SOX2 and LIN28) are sufficient to generate human iPS
cells. In addition to exhibiting pluripotent cell features,
the resulting integration-free human iPS cells have the
ability to generate hepatocyte-like cells and cardiac myo-
cytes following directed differentiation in culture.
Results
Generation of integration-free virus-free human induced
pluripotent stem cells
Human foreskin fibroblasts previously used for generat-
ing lentiviral-derived human iPS cells [13,14] were
co-transfected with four plasmid constructs coding for
OCT4, NANOG, SOX2 and LIN28 (Figure 1A). Our
protocol used plasmid vectors identical to those used to
generate the lentiviruses described by Yu et al [6]; how-
ever, the absence of packaging vectors from the trans-
fection prevented the possibility of generating virions. A
second transfection was carried out one week after the
first. Two weeks later, transfected cells were incubated
with the MEK inhibitor PD0325901 (StemGent). Four
weeks after the first transfection, human iPS-like colo-
nies were picked.
At the end of the reprogramming protocol, alkaline
phosphatase activity was evaluated (Figure 1B). Com-
pared to the lentivirus-based reprogramming protocol,
plasmid transfection led to a similar number of colonies
displaying alkaline phosphatase activity. However, even
though alkaline phosphatase activity is considered to be
a marker of pluripotency in embryonic stem cells [15], it
is detected early in the reprogramming process and does
not necessarily reflect a fully reprogrammed state [8].
In three independent experiments a total of 36 colo-
nies were collected whose morphology resembled that
of huES cells. Cells were collected by manual dissection
and seeded onto MEFs. Although we were unable to
culture the majority of the colonies as stable lines, a sin-
gle human iPS cell colony (iPSK3) was successfully
expanded for further analyses. As shown in Figure 2A,
iPSK3 cells displayed a morphology that was indistin-
guishable from human embryonic stem cells (H9). The
cells also possessed alkaline phosphatase activity (Figure
2A) and expressed pluripotent markers including OCT4
and SSEA4 (Figure 2B). In addition, FACS analyses
revealed that ≥ 99% of cells expressed OCT4, SSEA4,
TRA1-60 and TRA1-81, while in contrast the fibroblast
marker CD13 was not detected (Figure 2C). After
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subcutaneous injection into immunodeficient Rag2-/-;
Il2rgamma-/- mice, iPSK3 cells generated teratomas con-
taining tissues derived from all three germ layers (Figure
2D). Finally, G-banding of genomic DNA revealed a
normal karyotype (Figure 2E) and Short Tandem Repeat
analysis found that the DNA fingerprint of iPSK3 cells
matched that of the human foreskin fibroblast originally
used for reprogramming (Figure 2F).
Since the plasmids used to reprogram lacked
sequences required for replication in eukaryotic cells we
expected that exogenous DNA would by lost from
iPSK3 cells during cell division. We, therefore screened
for the presence of plasmid DNA by Southern blot and
PCR analysis of iPSK3 genomic DNA. Southern blot
analysis was performed after digestion by BamHI and
developed using a probe to detect the puromycin
N-acetyl transferase gene that is present on each of the
plasmids used for reprogramming but is absent from
human genome (Figure 3A right). Blots were stripped
and hybridized to a probe that detected FOXD3, to
ensure the presence of DNA in each sample (Figure 3A
left). While integrated exogenous DNA was detected in
lentiviral-derived human iPS cells (iPSC2 and iPSC6),
plasmid DNA was not detected in control huES cell
lines H9, H9.14 and H9.15 (two subclones of H9) or in
iPSK3 cells. Since genomic DNA was obtained by preci-
pitation from whole cell lysates, without separation
between cytosolic and nuclear compartments, the
absence of exogenous DNA by Southern blot suggests
that iPSK3 cells were also devoid of episomal plasmid
DNA (Figure 3A).
The absence of plasmid DNA was confirmed by per-
forming genomic PCR using primers that specifically
amplify puromycin N-acetyl-transferase sequence (Fig-
ure 3B). An amplification product was successfully
detected when DNA from control lentiviral-derived
iPSC2 cells was used as a template. In contrast, ampli-
cons were not identified in DNA from control H9 cells
Figure 1 Overview of approach used to generate iPS cells by transient transfection of plasmid DNA. A) Schematic and timeline of the
protocol used to generate human iPS cells by sequential transient transfection of plasmids expressing OCT4, NANOG, SOX2, and LIN28 cDNAs.
B) Photographs showing colonies expressing alkaline phosphatase activity after lentivirus-based reprogramming (left) or plasmid transfection-
based reprogramming (right) of human fibroblasts.
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Figure 2 Analysis of pluripotency of iPS cells generated by plasmid transfection. A) Micrographs comparing the morphology of the
plasmid-derived iPS cells (iPSK3) and human ES cell line H9.14 cultured on mitotically inactivated MEFs and alkaline phosphatase activity
identified by histochemistry (Scale bar = 100 μm). B) Immunostaining revealing the presence of OCT4 (red) and SSEA4 (green) in plasmid-derived
iPSK3 cells and control H9 human ES cells. Cell nuclei were detected using DAPI stain (Blue) (Scale bar = 100 μm). C) Representative FACS
analysis demonstrating that ≥ 99% of iPSK3 cells in culture (passage 8-10) express markers of pluripotency including OCT4, SSEA4, TRA1-60 and
TRA1-81. Cells expressing the fibroblast marker CD13 were not detected. D) Micrographs of H & E stained sections through teratomas that
formed from iPSK3 cells after injection into immune deficient mice. Cell types derived from all three germ layers - ectoderm, endoderm and
mesoderm (indicated with *) - were detected (Scale bar = 100 μm). E) Karyotype of iPSK3 cells revealed a normal distribution of 46
chromosomes with XY sex chromosomes. Chromosomal rearrangements were not detected by G-banding. F) STR analyses using CODIS primers
demonstrated that the DNA fingerprint of iPSK3 cells was indistinguishable from that of CRL2097 foreskin fibroblasts used as recipients for
reprogramming.
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or from iPSK3 cells. From these data we conclude that
the reprogrammed iPSK3 cells are devoid of plasmid
sequences, at least within the resolution offered by the
assays.
Differentiation of iPSK3 cells into hepatocyte-like cells
We previously reported that human iPS cells can be
used to efficiently generate cells that possess features
and functional characteristics that are similar to those of
human hepatocytes [14]. We, therefore, tested whether
iPSK3 cells retained competency to adopt a hepatic fate
by directed differentiation in culture. Following comple-
tion of the four-step differentiation protocol [14], cells
derived from iPSK3 cells displayed features that are
associated with hepatocytes. Such features included an
epithelial organization, large cytoplasmic-to-nuclear
ration, prominent nucleoli, the presence of lipid vesicles,
and the presence of binucleated cells in the culture (Fig-
ure 4A, see insert).
Differentiated cells were then incubated with 5-(and
6)-carboxy-2’-7’-dichlorofluorescein diacetate (DCF-DA).
DCF-DA is membrane permeable and becomes trapped
inside the cells after cleavage by intracellular esterase
into DCF and DA. DCF, however, can be secreted
between hepatocyte-like cells via bile canaliculi through
specific transporters [16]. Hepatocyte-like cells derived
from iPSK3 efficiently secreted the fluorescent com-
pound, demonstrating the presence of functional bile
transporters (Figure 4B; see inset, white arrow). Finally,
the differentiated cells also expressed several hepatic
markers including FoxA2, E-cadherin, HNF4a, a-
fetoprotein, and Albumin (Figure 4C). Overall, our data
suggest that the iPSK3 were competent to form hepato-
cyte-like cells.
Directed differentiation of human iPSK3 cells into cardiac
myocytes
To ensure that the cells’ ability to differentiate in culture
was not restricted to cells derived only from endodermal
lineages, we examined the potential of the iPSK3 cells to
differentiate toward a cardiac myocyte cell fate using a
directed cardiac myocyte differentiation protocol based
on previously published procedures [17,18]. Clusters of
rhythmically contracting cells were observed 2 weeks
following the start of the differentiation protocol and
continued to beat 40 days later (Additional file 1). The
beating areas expressed the transcription factor GATA4
(Figure 5A) and the cardiac-specific marker Troponin-T
in a striated manner, consistent with these cells being
cardiac myocytes (Figure 5A and inset).
Figure 3 Human iPSK3 cells are devoid of plasmid DNA. A) Southern blot analysis of genomic DNA from control iPS cells, iPSC6 and iPSC2
[14], generated by lentivirus transduction, human ES cells (H9, H9.14, and H9.15), or iPSK3 cells. DNA was digested with BamH1 and blots were
hybridized with probes to detect FOXD3 as a loading control (left) or the puromycin N-acetyl transferase gene (right), which is present in both
plasmid and lentiviral vectors. B) PCR analysis on total DNA extracted from either human ES cells (H9, H9.14 and H9.15), which lack exogenous
DNA sequences, iPSC2 cells which contain integrated viral sequences, and iPSK3 cells using primers that specifically recognize the puromycin
N-acetyl-transferase gene. PCR amplification without template DNA was performed to exclude DNA contamination. Primers that specifically
recognize a human Alu sequence were used for loading control.
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Cytosolic calcium transients were monitored using the
fluo-4 AM fluorescent indicator, which is calcium sen-
sitive. Figure 5B shows a montage of rhythmic oscilla-
tion of intracellular calcium waves based on video
acquisition (Additional file 2). Analysis of intracellular
calcium released from individual cells among the
beating network (Figure 5C, upper) showed a heteroge-
neous population consisting of atrial-like cardiac myo-
cytes (Figure 5C, lower left) that displayed a higher
frequency of intracellular calcium oscillation and
shorter periodicity, along with ventricular-like cardiac
myocytes (Figure 5C, lower right), with a lower
Figure 4 Differentiation of iPSK3 into hepatocyte-like cells. A) Micrograph showing the epithelial-like organization of iPSK3 upon hepatic
differentiation. Higher resolution (inset) showing a binucleated cell. Scale bar = 100 μm. B) The hepatocyte-like cells derived from iPSK3
metabolized and transported 5-(and 6)-carboxy-2’-7’-dichlorofluorescein diacetate between cells (high-resolution inset, white arrow), indicating
the presence of functional bile transporters. C) Immunocytochemistry revealed the presence of proteins commonly associated with hepatocytes
including, FoxA2, Hnf4a, E-cadherin, a-fetoprotein and Albumin. Scale bar = 100 μm.
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frequency of intracellular oscillation and longer peri-
ods. These data confirm that iPSK3 cells can be
induced to differentiate into distinct populations of
functional cardiac myocytes in culture.
Discussion
In this report, we describe the generation of human iPS
cells devoid of exogenous DNA by the simple transient
transfection of plasmids that express reprogramming
factors. These newly reprogrammed somatic cells display
pluripotent markers and were found to form teratomas
in immunodeficient mice that were composed of all
three germ layers. In addition, our data demonstrate
that the iPSK3 cells produced by this process could
form hepatocyte-like cells and contracting cardiac myo-
cytes upon directed differentiation in culture.
Figure 5 Differentiation of iPSK3 cells into cardiac cells. A) Immunocytochemistry revealed that clusters of contracting cells expressed
cardiac markers including GATA4 in the cells nuclei, detected by DAPI staining, and cardiac-specific Troponin T. High-resolution images revealed
a striated pattern of Troponin T staining as expected for a protein associated with myofibrils (Scale bar = 100 μm). B) Intracellular calcium
concentration measurements using the fluo-4 AM fluorescent indicator identified rhythmic oscillation correlating with cardiac cell contraction
(0.7s between each picture; see movie S2 in supplemental data). C) Contracting cells within the cluster exhibit both an atrial-like calcium
transient (cell 1 and 2, lower left panel) and a ventricular-like calcium transient (cell 3 and 4, lower right panel).
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Despite the observation that similar numbers of colo-
nies expressing alkaline phosphatase activity were identi-
fied between lentiviral transduction and plasmid
transfection, the use of plasmids is less efficient for full
reprogramming of somatic cells. Based on the successful
isolation of a single fully reprogrammed colony, the effi-
ciency of human iPS cell reprogramming by plasmid
transfection (1 iPS cell from 300,000 fibroblasts) was
similar to that reported for the use of adenovirus
(0.0002%) [10], which is approximately ten-fold lower
(0.01%) when reprogramming is performed with lenti-
viruses [6]. This lower efficiency presumably reflects a
reduction in sustainable expression of the reprogram-
ming factors because the presence of plasmid DNA
within the cells is transient. A substantial effort by mul-
tiple labs has resulted in the description of small mole-
cules that can enhance the efficiency of reprogramming
(See review by Li and Ding [19]). For example increases
up to 200-fold in reprogramming efficiency have been
reported by including antagonists of TGFbeta signaling
in addition to MEK-ERK inhibitors and passaging the
cells in the presence of Thiazovivin [20]. In addition,
inclusion of Valproic Acid or Sodium Butyrate may
enhance complete reprogramming [3,4]. It therefore
seems likely that such drug combinations could be used
to increase the efficiency of reprogramming by transient
transfection of expression plasmids.
The main advantage of the current approach is that it
allows direct reprogramming of human somatic cells
into human iPS cells devoid of exogenous DNA without
the need for extensive experimental procedures [12,13].
While several other procedures have been described for
producing iPS cells free of integrating DNA, most
require some level of specialized knowledge of virology
or biochemistry. Although the frequency of recovering
completely reprogrammed iPS cells is lower than using
lentiviral transduction, the simplicity and accessibility of
using transient transfection should also compensate for
the reduced efficiency.
Conclusions
In conclusion, we have shown that simple transient
transfection of plasmid DNA encoding reprogramming
factors is sufficient to generate human iPS cells from pri-
mary fibroblasts that are free of exogenous DNA integra-
tions. This approach is simple, highly accessible and
could expand the use of iPS cells in the study of human
disease and development, as well as increase the availabil-
ity of safer iPS cells for potentially therapeutic uses.
Methods
Cell culture
Human iPS cells were cultured on mitotically inactivated
mouse embryonic fibroblasts (MEFs) in a stem cell
medium composed of Dulbecco’s modified Eagle’s med-
ium/Ham’s F-12 (DMEM/F12) supplemented with 20%
knockout serum (Invitrogen, Carlsbad, CA), non-
essential amino acids solution (Invitrogen, Carlsbad,
CA), glutamine (Invitrogen, Carlsbad, CA), penicillin/
streptomycin (Invitrogen, Carlsbad, CA) and bFGF
(4 ng/ml; Invitrogen, Carlsbad, CA) and maintained
under low oxygen conditions (4% O2; 5% CO2) for 7
days. Cells were manually passaged once a week on
MEFs, by using Accutase (Millipore, Billerica, MA) on
Matrigel, or on a recombinant protein substrate (Ste-
mAdhere™, Primorigen Inc, Madison, WI) as described
previously [21]. For differentiation experiments, MEF-
conditioned medium was used to maintain pluripotency
while transferring the cells onto feeder cell-free Matri-
gel-coated plates. All work carried out using human iPS
cells was approved by the MCW Human Stem Cell
Research Oversight Committee (hSCRO approval# 09-
005) committee and all work performed using animals
was approved by the MCW IACUC.
Reprogramming protocol
On day 0, 1 × 105 human foreskin fibroblasts (ATCC
cell line CRL2097) were plated on an uncoated 100 mm
dish. To introduce DNA, pSin vectors coding for OCT4,
NANOG, SOX2, and LIN28 [6] were mixed with Fugene
6 (Roche Applied Science, Indianapolis, IN) in a 2:1
ratio of Fugene:DNA and transfections were performed
on day 1 and 8 of reprogramming. Stem cell medium
was used for all cell culture starting on day 2 of repro-
gramming, and the MEK1 inhibitor PD0325901 (Stem-
Gent, Cambridge, MA) was added to the medium on
day 15 at a final concentration of 1 μM. The medium
was changed daily. After four to five weeks, emerging
colonies were manually collected and plated on mitoti-
cally-inactivated MEFs for subsequent characterization.
Lentivirus-based reprogramming utilized the same cul-
ture conditions as described above; however, the cells
were infected with concentrated replication-incompetent
pseudotyped lentiviruses that express OCT4, NANOG,
SOX2 and LIN28.
Alkaline Phosphatase activity
Pluripotent cells in culture on MEFs were fixed with 4%
paraformaldehyde for 2 min at room temperature. The
cells were then rinsed with TBST (20 mM Tris-HCl, pH
7.4, 0.15 M NaCl, 0.05% Tween-20) and incubated for
15 min at room temperature with a mixture of Fast Red
Violet, Naphtol AS-BI phosphate solution and water
(2:1:1) from the Alkaline Phosphatase Detection Kit
(Millipore, Billerica, MA) according to the manufac-
turer’s protocol. Following staining, the cells were rinsed
with TBST and covered with phosphate-buffered saline
(PBS).
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Karyotyping and DNA fingerprinting
Karyotyping and DNA fingerprinting of the human
induced pluripotent cell lines was performed by Cell Line
Genetics, Madison, WI (http://www.clgenetics.com/).
Teratoma assay
Human iPS cell line, iPSK3, was cultured on MEFs with
one dense 60 mm plate used per assay. Cells were
manually removed using the StemPro EZPassage tool
(Invitrogen), collected by centrifugation and resus-
pended in 250 μl of Matrigel (2 mg/ml in DMEM-F12;
BD Bioscience). Approximatively 2 × 106 cells were then
injected into the posterior dorsal side of immunodefi-
cient Rag2-/-; Il2rg-/- mice using a 27G needle. Resulting
teratomas were dissected 8 to 9 weeks after injection,
fixed overnight with Zinc-formalin and embedded in
paraffin before 4 μm sections were stained with hema-
toxilin and eosin. All animal procedures were approved
by the MCW IACUC.
Immunostaining
Cultured cells were fixed with 4% paraformaldehyde for
30 min at room temperature, permeabilized with 0.5%
Triton X-100 in PBS for 15 min and blocked with 3%
BSA in PBS for 15 min. Cells were incubated overnight
at 4°C with primary antibodies diluted in 1% BSA
in PBS (Oct3/4 1:500; SSEA4 1:100; GATA4 1:500; Car-
diac Troponin T 1:100; FoxA2 1:250; Hnf4a 1:500;
E-cadherin 1:1000; alpha-fetoprotein 1:500; Albumin
1:500). After incubation with respective secondary anti-
bodies (Alexa Fluor 488 or 568; Invitrogen, Carlsbad,
CA) for 1 h at room temperature, cell nuclei were iden-
tified using DAPI and samples were mounted using Pro-
Long Gold Antifade Mounting Reagent (Invitrogen,
Carlsbad, CA).
Flow Cytometry analysis
Cultured cells were dissociated using a PBS-based Cell
Dissociation Buffer (Invitrogen), washed with 0.25% BSA
in PBS and stained 1 hour with antibodies directed
against CD13-Alexa 488 nm, OCT3/4-PerCP, SSEA4-
Alexa 488 nm, TRA1-60-PE or TRA1-81-PE (CD13 1
μg; Oct3/4 1 μg; SSEA4 0.5 μg; TRA1-60 1 μg; TRA1-81
1 μg) at 4°C. Flow cytometry analysis was performed
using the Guava EasyCyte Minisystem (Millipore, Biller-
ica, MA).
Southern blot and PCR analysis
The cells were incubated overnight with a cell lysis buffer
(4 M urea, 10 mM CDTA, 0.5% sarkosyl, 0.1 M Tris-HCL,
pH 8.0, 0.2 M NaCl) and 1 mg/ml proteinase K at 55°C.
The next day, isopropanol was added and the DNA was
spooled out and dissolved in 10 mM Tris-HCL, pH 8.0,
0.1 mM EDTA. Genomic DNA was digested with BamHI
and resolved on a 0.7% agarose gel at 23 V overnight.
After denaturing, DNA from the gel was transferred to a
Zetaprobe GT membrane (Bio-Rad, Hercules, CA).
Fragments were amplified by PCR to generate a radioac-
tively-labeled probe that recognized puromycin N-acetyl-
transferase (which confers resistance against puromycin in
eukaryotic cells) or FOXD3 as a control for all DNA sam-
ples. PCR analysis was performed on 2 ng of DNA using
specific primers for puromycin N-acetyl-transferase (Puro)
and human Alu repeat as a loading control. Primers used
to generate probes and amplicons: Puro, GTCACC-
GAGCTGCAAGAACT and GTCCTTCGGGCACTC-




Pluripotent cells were differentiated using the method
described previously [14]. To assess cell polarity hepato-
cyte-like cells were incubated for 10 min with 5-(and 6)-
carboxy-2’-7’-dichlorofluorescein diacetate (DCF-DA;
Biotium) at a final concentration of 2 μg/ml. Cells were
then washed three times with hepatocyte culture med-
ium and immediately observed under a fluorescent
microscope.
Cardiac myocyte differentiation
Pluripotent cells were manually dissected from MEFs
and plated on 6-well plates pre-coated with Matrigel
and kept under 4% O2/5% CO2 at 37°C for 1 week. To
induce cardiac differentiation, cells were incubated for 5
days in RPMI/B27 medium (Invitrogen, Carlsbad, CA),
supplemented with 50 ng/ml human recombinant Acti-
vin A (R & D systems, Minneapolis, MN) and 10 ng/ml
BMP4 (Peprotech, Inc, Rocky Hill, NJ) in a 4% O2/5%
CO2 atmosphere. After 5 days, treated cells were then
placed in a 5% CO2 and ambient oxygen atmosphere,
and the RPMI/B27 medium was changed every 2 days.
Clusters of beating cells were observed 15-20 days after
starting the differentiation process.
Intracellular calcium measurements
Intracellular calcium transients in human iPS cell-
derived cardiac myocytes were measured using fluo-4
AM fluorescent indicator (Invitrogen, Carlsbad, CA) in
RPMI/B27 medium. Fluo-4 AM (2 μM) was loaded for
20 min at 37°C, followed by a 5 min dye washout.
Rhythmically contracting areas were visualized using a
laser-scanning confocal microscope (Eclipse TE2000-U;
Nikon, Tokyo, Japan) with a Plan Apo 10× air NA 0.45
objective lens (Nikon Corp, Tokyo). Images were
acquired every 700 ms using EZ-C1 software (EZ-C1
2.10, Nikon Corp, Tokyo), and data were analyzed with
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MetaMorph 6.1 software (Universal Imaging, West Che-
ster, PA).
Additional material
Additional file 1: Beating cluster of cardiac myocytes derived from
iPSK3 cells.
Additional file 2: Calcium transient visualization of a beating cluster
of iPSK3 cell-derived cardiac myocytes in the presence of a fluo-4
AM fluorescent indicator.
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